StatLab Medical today announced the launch of new U.S.-based manufacturing capabilities, advancing its multi-year "in-region, for-region" strategy to ensure scalable production of reagents for pathology labs nationwide.
The latest milestone—insourcing injection-molded pre-fill containers—helps solidify StatLab’s position as one of the top U.S. manufacturers of formalin pre-fills, producing nearly 100 million units annually.
In addition to bringing injection molding for pre-fill containers in-house, StatLab will also begin blow molding gallon bottles in the second quarter. Production capacity for cassettes continues to grow as well, with new injection molding cells added at the Arlington facility.
StatLab also announced it will absorb any tariff-related fees associated with products manufactured in its European facilities when selling directly to U.S. laboratories. These products include PiSmart cassette and slide printers, KT microscope slides, and KT coverglass. By using its U.S. and European manufacturing capabilities, StatLab said it is able to offer consumables for the full pathology workflow protected from tariff impact.
